Back to results
US 2016/0354342 A1Published application
Compositions and methods for the treatment of acid-related gastrointestinal disorders containing a dithiolane compound and a gastric acid secretion inhibitor.
OwnerMuslim D. Shahidinventor
Life of this patent
Estimating the term…
Abstract
A treatment for acid related gastrointestinal disorders. The methods and compounds described include gastric acid secretion inhibitors in combination with alpha lipoic acid (ALA) or related compounds. ALA is not known as a treatment for acid related gastrointestinal disorders; however, when combined with certain compounds used in the treatment of acid related gastrointestinal disorders, ALA significantly improves existing treatments.
Claims16
A method of treating acid related gastrointestinal disorders comprising:
- administering orally at an effective daily dose a mixture of between 10 mg and 1500 mg of a dithiolane compound and/or one or more modified derivatives thereof, and between 25 mg and 800 mg of an H2 receptor antagonist and/or one or more modified derivatives thereof.
A method of treating acid related gastrointestinal disorders comprising:
- administering a therapeutically effective amount a mixture of a dithiolane compound and/or one or more modified derivatives thereof, and an H2 receptor antagonist and/or one or more modified derivatives thereof.
A method of treating acid related gastrointestinal disorders comprising:
- administering a therapeutically effective amount a mixture of a dithiolane compound and/or one or more modified derivatives thereof, and an H2 receptor antagonist and/or one or more modified derivatives thereof.
Dependencies are inferred from the claim text.